Mavis Agnes Kisakye: Strengthening Healthcare Access for Bleeding Disorders in Uganda
Mavis Agnes Kisakye, Health Officer, EVD Response at Uganda Red Cross Society, shared a post on LinkedIn:
”The Haemophilia Foundation of Uganda (HFU), with the generous support of the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation (NNHF), continues to push the boundaries of healthcare accessibility.
Our team, led by our dedicated Project Lead, recently traveled to Kabale and Kisoro to establish and integrate Haemophilia and other bleeding disorder services into these regional hospitals.
Navigating the land of a hills requires resilience, as the geography is defined by its iconic sharp corners and steep terrain.
However, the need for care is even more pressing than the landscape is challenging.
The leadership and teams in these districts were ready and waiting for our arrival as early as yesterday, recognizing the urgent demand within their catchment areas.
Kisoro and Kabale serve as critical touchpoints for both local residents and refugee populations.
By establishing care here, we are ensuring that no patient is left behind due to distance or displacement.
We remain committed to building a sustainable healthcare structure that brings hope and access to every corner of Uganda.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026